Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 17/20 | 0.78 |
| ▸ | PTGS2 | P35354 | 14/20 | 0.78 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.65 |
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CA2 | P00918 | 3/20 | 0.60 |
| ▸ | CA9 | Q16790 | 3/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15460596 | 0.95 | EPHX2 (0.85) | EPHX2PTGS2AKR1C3CA1CA2 | |
| SCHEMBL15460592 | 0.91 | EPHX2 (0.77) | EPHX2PTGS2AKR1C3CA1CA2 | |
| SCHEMBL15460599 | 0.90 | EPHX2 (0.83) | EPHX2PTGS2AKR1C3CA1CA2 | |
| SCHEMBL15463062 | 0.88 | EPHX2 (0.78) | EPHX2PTGS2AKR1C3CA1CA2 | |
| SCHEMBL31738527 | 0.87 | EPHX2 (1.00) | EPHX2PTGS2AKR1C3CA1CA2 | |
| SCHEMBL9938907 | 0.87 | EPHX2 (1.00) | EPHX2PTGS2AKR1C3CA1CA2 | |
| SCHEMBL15460591 | 0.87 | EPHX2 (0.79) | EPHX2PTGS2AKR1C3 | |
| SCHEMBL9937759 | 0.87 | EPHX2 (1.00) | EPHX2PTGS2AKR1C3CA1CA2 | |
| SCHEMBL15460598 | 0.86 | EPHX2 (0.88) | EPHX2PTGS2AKR1C3CA1CA2 | |
| SCHEMBL15460595 | 0.85 | PTGS2 (0.75) | EPHX2PTGS2CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096532-B2 | Pyrazole inhibitors of COX-2 and sEH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-08-04 | — | — | US | disclosed |
| US-20140038923-A1 | PYRAZOLE INHIBITORS OF COX-2 AND SEH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140038923-A1 | PYRAZOLE INHIBITORS OF COX-2 AND SEH | PTGES2, PTGS2, PTGES3 | EPHX2 5/4885PTGS2 2/4885AKR1C3 1894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.